Dietary patterns, supplement use, and the risk of benign prostatic hyperplasia

Current Urology Reports

Volumn 10, Issue 4, 2009, Pages 279-286

  Poon, Kenneth S ^a   McVary, Kevin T ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

STEROID 5ALPHA REDUCTASE; STEROID 5ALPHA REDUCTASE INHIBITOR; TRACE ELEMENT;

COHORT ANALYSIS; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; EXERCISE; HUMAN; LIFESTYLE AND RELATED PHENOMENA; MACRONUTRIENT; NUTRITIONAL ASSESSMENT; PHYTOTHERAPY; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATE HYPERTROPHY; REVIEW; RISK FACTOR; SUPPLEMENTATION; UNITED STATES;

DIET; DIETARY SUPPLEMENTS; HUMANS; MALE; PROSTATIC HYPERPLASIA; RISK FACTORS;

EID: 68149162169     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-009-0046-3     Document Type: Review

References (54)

1. S. Bent C. Kane K. Shinohara 2006 Saw palmetto for benign prostatic hyperplasia N Engl J Med 354 557 566 (Pubitemid 43209103)
2. S.J. Berry D.S. Coffey P.C. Walsh L.L. Ewing 1984 The development of human benign prostatic hyperplasia with age J Urol 132 474 479 (Pubitemid 14026148)
3. Roehrborn CG, McConnell JD: Benign prostatic hyperplasia: etiology, pathophysiology, epidemiology, and natural history. In Campbell-Walsh Urology, edn 9. Edited by Wein AJ, Kavoussi LR, Novick AC, et al. Philadelphia: Elsevier; 2006:2727.
4. B.T. Helfand R.M. Evans K.T. [tmp] McVary 2009 Medical treatment of LUTS/BPH: analysis of 8.7 million American men AUA Abstracts J Urol 181 647
5. A.T. Cockett M.J. Barry H.L. Holtgrewe 1992 Indications for treatment of benign prostatic hyperplasia. The American Urological Association Study Cancer 70 280 283
6. J.T. Wei E. Calhoun S.J. Jacobsen 2005 Urologic Diseases in America project: benign prostatic hyperplasia J Urol 173 1256 1261 (Pubitemid 40380548)
7. C.S. Saigal G. Joyce 2005 Economic costs of benign prostatic hyperplasia in the private sector J Urol 173 1309 1313 (Pubitemid 40380559)
8. J.M. Hollingsworth J.T. Wei 2006 Economic impact of surgical intervention in the treatment of benign prostatic hyperplasia Rev Urol 8 Suppl3 S9 S15
9. Ranbaxy Laboratories, Ltd.: Ranbaxy receives tentative approval from US FDA for tamsulosin capsules. Available at http://www.ranbaxy.com/news/newsdisp. aspx?cp=844&flag=ARC. Accessed March 2009.
10. K. Dreikorn 2002 The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia World J Urol 19 426 435
11. Food and Drug Administration Act: HR 15315, 92nd Cong, 2nd Sess (1972). Amended with the Dietary Supplement Health and Education Act (DHSEA) Public Law 103-417 (1994).
12. P.A. De Smet 2002 Herbal remedies N Engl J Med 347 2046 2056 (Pubitemid 35461662)
13. P.A. De Smet 2004 Health risks of herbal remedies: an update Clin Pharmacol Ther 76 1 17 (Pubitemid 38844729)
14. R. Ko R.D. Wilson S. Loscutoff 2003 PC-SPES Urology 61 1292 (Pubitemid 36694035)
15. R.M. Pitkin 2007 Folate and neural tube defects Am J Clin Nutr 85 285S 288S (Pubitemid 46067650)
16. M.F. Holick T.C. Chen 2008 Vitamin D deficiency: a worldwide problem with health consequences Am J Clin Nutr 87 1080S 1086S (Pubitemid 351549267)
17. S.M. Lippman E.A. Klein P.J. Goodman 2009 Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT) JAMA 301 39 51
18. M.H. Blanker F.P. Groeneveld A. Prins 2000 Strong effects of definition and nonresponse bias on prevalence rates of clinical benign prostatic hyperplasia: the Krimpen study of male urogenital tract problems and general health status BJU Int 85 665 671 (Pubitemid 30192831)
19. A.R. Kristal K.B. Arnold J.M. Schenk 2007 Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial J Urol 177 1395 1400 (Pubitemid 46436001)
20. E.A. Platz I. Kawachi E.B. Rimm 2000 Race, ethnicity and benign prostatic hyperplasia in the health professionals follow-up study J Urol 163 490 495 (Pubitemid 30060502)
21. M.J. Barry F.J. Fowler Jr M.P. O'Leary 1992 The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association J Urol 148 1549 1557
22. K.K. Tsang W.M. Garraway 1993 Impact of benign prostatic hyperplasia on general well-being of men Prostate 23 1 7 (Pubitemid 23250081)
23. X. Badia F. Rodriguez J. Carballido 2001 Influence of sociodemographic and health status variables on the American Urological Association symptom scores in patients with lower urinary tract symptoms Urology 57 71 77 (Pubitemid 32065823)
24. C.G. Roehrborn J.E. Oesterling S. Auerbach 1996 The Hytrin Community Assessment Trial study: a one-year study of terazosin versus placebo in the treatment of men with symptomatic benign prostatic hyperplasia. HYCAT Investigator Group Urology 47 159 168 (Pubitemid 26075268)
25. J.D. [tmp] McConnell C.G. Roehrborn O.M. Bautista 2003 The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia N Engl J Med 349 2387 2398 (Pubitemid 37542987)
26. S.M. Sech J.D. Montoya P.A. Bernier 1998 The so-called "placebo effect" in benign prostatic hyperplasia treatment trials represents partially a conditional regression to the mean induced by censoring Urology 51 242 250 (Pubitemid 28093175)
27. R.C. Dedhia K.T. [tmp] McVary 2008 Phytotherapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia J Urol 179 2119 2125
28. N. Eikelis M. Schlaich A. Aggarwal 2003 Interactions between leptin and the human sympathetic nervous system Hypertension 41 1072 1079 (Pubitemid 36548605)
29. R.J. Troisi S.T. Weiss D.R. Parker 1991 Relation of obesity and diet to sympathetic nervous system activity Hypertension 17 669 677
30. G.G. Gordon K. Altman A.L. Southren 1976 Effect of alcohol (ethanol) administration on sex-hormone metabolism in normal men N Engl J Med 295 793 797
31. J.F. Dorgan J.T. Judd C. Longcope 1996 Effects of dietary fat and fiber on plasma and urine androgens and estrogens in men: a controlled feeding study Am J Clin Nutr 64 850 855 (Pubitemid 26392869)
32. J.C. Nickel C.G. Roehrborn M.P. O'Leary 2008 The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial Eur Urol 54 1379 1384
33. G. Kramer M. Marberger 2006 Could inflammation be a key component in the progression of benign prostatic hyperplasia? Curr Opin Urol 16 25 29 (Pubitemid 43041217)
34. G. Kramer D. Mitteregger M. Marberger 2007 Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol 51 1202 1216 (Pubitemid 46436310)
35. K.T. [tmp] McVary 2006 Non-steroidal anti-inflammatory drugs and urinary retention Lancet 367 195 196 (Pubitemid 43107653)
36. A.R. Kristal K.B. Arnold J.M. Schenk 2008 Dietary patterns, supplement use, and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial Am J Epidemiol 167 925 934
37. S. Suzuki E.A. Platz I. Kawachi 2002 Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia Am J Clin Nutr 75 689 697 (Pubitemid 34250682)
38. E.A. Platz E.B. Rimm I. Kawachi 1999 Alcohol consumption, cigarette smoking, and risk of benign prostatic hyperplasia Am J Epidemiol 149 106 115 (Pubitemid 29039513)
39. D. Kang G.L. Andriole R.C. Van De Vooren 2004 Risk behaviours and benign prostatic hyperplasia BJU Int 93 1241 1245 (Pubitemid 38823945)
40. E.A. Platz I. Kawachi E.B. Rimm 1998 Physical activity and benign prostatic hyperplasia Arch Intern Med 158 2349 2356 (Pubitemid 28536488)
41. J.B. Meigs B. Mohr M.J. Barry 2001 Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men J Clin Epidemiol 54 935 944 (Pubitemid 32771319)
42. C.V. Iannucci D. Capoccia M. Calabria F. Leonetti 2007 Metabolic syndrome and adipose tissue: new clinical aspects and therapeutic targets Curr Pharm Des 13 2148 2168 (Pubitemid 47078770)
43. S. Kasturi S. Russell K.T. [tmp] McVary 2006 Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia Curr Urol Rep 7 288 292 (Pubitemid 44623991)
44. S. Rohrmann E. Smit E. Giovannucci E.A. Platz 2004 Associations of obesity with lower urinary tract symptoms and noncancer prostate surgery in the Third National Health and Nutrition Examination Survey Am J Epidemiol 159 390 397 (Pubitemid 38200773)
45. E. Giovannucci E.B. Rimm C.G. Chute 1994 Obesity and benign prostatic hyperplasia Am J Epidemiol 140 989 1002 (Pubitemid 24373003)
46. S.E. Dahle A.P. Chokkalingam Y.T. Gao 2002 Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia J Urol 168 599 604 (Pubitemid 34793304)
47. S. Rohrmann E. Giovannucci W.C. Willett E.A. Platz 2007 Fruit and vegetable consumption, intake of micronutrients, and benign prostatic hyperplasia in US men Am J Clin Nutr 85 523 529 (Pubitemid 46220958)
48. J. Satia-Abouta R.E. Patterson R.N. Schiller A.R. Kristal 2002 Energy from fat is associated with obesity in U.S. men: results from the Prostate Cancer Prevention Trial Prev Med 34 493 501 (Pubitemid 34971670)
49. G.L. Ambrosini N.H. de Klerk D. Mackerras 2008 Dietary patterns and surgically treated benign prostatic hyperplasia: a case control study in Western Australia BJU Int 101 853 860 (Pubitemid 351347718)
50. A. Tavani E. Longoni C. Bosetti 2006 Intake of selected micronutrients and the risk of surgically treated benign prostatic hyperplasia: a case-control study from Italy Eur Urol 50 549 554 (Pubitemid 44189041)
51. S. Rohrmann E. Smit E. Giovannucci E.A. Platz 2004 Association between serum concentrations of micronutrients and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey Urology 64 504 509 (Pubitemid 39200747)
52. A.R. Johnson A. Munoz J.L. Gottlieb D.F. Jarrard 2007 High dose zinc increases hospital admissions due to genitourinary complications J Urol 177 639 643 (Pubitemid 46054024)
53. R.S. DiPaola R.A. Morton 2006 Proven and unproven therapy for benign prostatic hyperplasia N Engl J Med 354 632 634 (Pubitemid 43209111)
54. A. Ishani R. [tmp] MacDonald D. Nelson 2000 Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative metaanalysis Am J Med 109 654 664 (Pubitemid 30950622)